Início › Câncer de Mama › Connecticut › Bridgeport
Ensaios clínicos de Câncer de Mama em Bridgeport, CT
21 estudos para Câncer de Mama estão buscando participantes em locais em Bridgeport e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RecrutandoFase 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · a 18 mi de distância
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecrutandoFase 3
- Research Site, Stony Brook · a 18 mi de distância
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RecrutandoFase 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · a 4 mi de distância
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · a 5 mi de distância
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Recrutando
- Stony Brook Cancer Center, Stony Brook · a 18 mi de distância
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RecrutandoFase 1/2
- Stony Brook University Hospital, Stony Brook · a 18 mi de distância
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RecrutandoFase 3
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecrutandoFase 3
- Stony Brook University Cancer Center, Stony Brook · a 18 mi de distância
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RecrutandoFase 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · a 19 mi de distância
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · a 19 mi de distância
- New York Cancers & Blood Specialists, Port Jefferson Station · a 19 mi de distância
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecrutandoFase 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · a 4 mi de distância
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · a 5 mi de distância
- e mais 1
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RecrutandoFase 2
- Stony Brook Cancer Center, Stony Brook · a 18 mi de distância
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RecrutandoFase 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · a 4 mi de distância
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · a 5 mi de distância
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
RecrutandoFase 1
- New York Cancer and Blood Specialists, Port Jefferson Station · a 19 mi de distância
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RecrutandoFase 3
- Stony Brook University Cancer Center, Stony Brook · a 18 mi de distância
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RecrutandoFase 3
- Smilow Cancer Hospital - Fairfield, Fairfield · a 5 mi de distância
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecrutandoFase 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · a 4 mi de distância
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · a 5 mi de distância
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RecrutandoEstudo observacional
- Stony Brook Medicine, Stony Brook · a 18 mi de distância
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
RecrutandoFase 1 inicial
- Stony Brook Breast Center, Stony Brook · a 18 mi de distância
Definitive Radiation Therapy for Inoperable Breast Cancer
Recrutando
- Stony Brook University Cancer Center, Stony Brook · a 18 mi de distância
Definitive Radiation for High-Risk Spine Metastases
RecrutandoFase 2
- Stony Brook University Hospital, Stony Brook · a 18 mi de distância
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RecrutandoEstudo observacional
- Stony Brook University Cancer Center, Stony Brook · a 18 mi de distância
Ensaios de Câncer de Mama em outras cidades
- New York City, NY136 estudos
- Houston, TX126 estudos
- Boston, MA112 estudos
- Nashville, TN81 estudos
- Los Angeles, CA73 estudos
- Edison, NJ68 estudos
- St. Louis, MO64 estudos
- Queens, NY64 estudos
- Durham, NC64 estudos
- Chicago, IL59 estudos
- Philadelphia, PA56 estudos
- Dallas, TX55 estudos
Outros estudos em Bridgeport
- Câncer de Pulmão de Não Pequenas Células14 estudos
- Câncer de Pulmão13 estudos
- Leucemia Mieloide Aguda12 estudos
- Doença Cardiovascular9 estudos
- Câncer (todos os tipos)8 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço8 estudos
- Câncer Metastático7 estudos
- Insuficiência Cardíaca7 estudos
- Aneurisma Cerebral6 estudos
- Mieloma Múltiplo6 estudos
- Câncer de Próstata6 estudos
- Câncer de Ovário5 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.